The Sturge-Weber Foundation is Committed to Advocacy.
Members of Congress are directly responsible for Federal programs that advance medical research, facilitate treatment development, and improve the quality and accessibility of healthcare. As a rare disease, it is safe to assume that lawmakers have little to no understanding of Sturge-Weber syndrome and associated conditions and the unique needs of affected individuals. The lack of information on Capitol Hill means that valuable medical research and public health activities may overlook our community.
The best way to ensure that Congress makes decisions, laws, and policies that empower our community is to use your voice and your story to personally educate your elected officials about the condition, the community, and contemporary issues. Connecting with your Members of Congress is easier than you might think. The Foundation is here to educate, assist and support you every step of the way.
World Orphan Drug Congress
The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
ARVO
The ARVO Annual Meeting is the premier gathering for eye and vision scientists at all career stages, students, and those in affiliated fields to share the latest research findings and collaborate on innovative solutions.
Monthly Advocacy Update
On a regular basis, the Foundation releases a written update on key issues and our efforts on Capitol Hill. These updates often include instructions on how you can contribute to advancing key issues.
Capitol Hill Advocacy Day
Volunteer advocates travel to Washington, DC, each year for comprehensive advocacy training and meetings with their Members of Congress. This event is an outstanding opportunity to learn about the issues and build relationships with the offices of your elected officials.
SWF Supported Sign-Ons:
-
4/2/24 | We are happy to announce the submission of the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative and the Neurology Drug Program (NDP) sign-on letters. The BRAIN Initiative letter was submitted to the House and Senate Subcommittees on Labor, Health, and Human Services and Education Appropriations. The BRAIN Initiative is revolutionizing our understanding of the brain and offering hope for the millions of individuals impacted by brain diseases, disorders, and injuries.
-
4/2/24 | We are happy to announce the submission of the Neurology Drug Program (NDP) sign-on letter. the NDP letter was submitted to the House and Senate Subcommittees on Agriculture, Rural Development, and Food and Drug Administration Appropriations. Support for this program will allow the FDA to gain the expertise to develop policies and guidance that keep pace with emerging brain science.
-
One in three Americans will have a brain or nervous system disorder sometime in their life, and the cost of treating neurological disorders is nearly $1.5 trillion each year. The BRAIN Initiative is revolutionizing our understanding of the brain and offering hope for the millions of individuals impacted by brain diseases, disorders, and injuries.
-
As your subcommittees begin to craft FY 2025 appropriation legislation, we ask that you provide $5 million for this important program, an
increase of $3 million. Funding at this level will help advance discoveries in all areas of brain health including neurodevelopmental, neurodegenerative, psychiatric, brain injuries, and more. -
Our organization is proud to join together with epilepsies stakeholders across the United States in asking President Biden to increase funding for epilepsies research.
-
Support for HR 485 Prohibiting the use of Quality Adjusted Life Years (QALY) in federal programs with Haystack Project sign-on information.
-
Would ensure that employer plans/PBMs offer an expedient and medically reasonable step therapy exceptions process. This will empower individuals to navigate their insurance and help them access the treatments they need in time.
-
Over 100 patient and provider organizations, including The Sturge-Weber Foundation, are asking Congress to pass PBM reform and include the #SafeStepAct to help patients directly. The Safe Step Act (S.652/HR2630) could potentially be included in a PBM reform bill that is being worked on in Congress.
-
NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) Coalition, representing millions of Americans with chronic conditions and diseases of the bones, joints, muscles and skin, as well as the professionals who serve them, write in strong support of the National Institutes of Health (NIH) Clinical Trial Diversity Act (H.R. 3503).
-
Dr. Kristen Kelly, Dermatology, California"The Foundation advocates for the patients both on a national level at Congress and then throughout a variety of other funding agencies."
